The U.S. Department of Health and Human Services and NIH have announced "Generation Gold Standard," a next-generation universal vaccine platform using beta-propiolactone-inactivated whole-virus technology.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.